Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Nov 20;59(11):2047.
doi: 10.3390/medicina59112047.

Multidisciplinary Rehabilitation after Hyaluronic Acid Injections for Elderly with Knee, Hip, Shoulder, and Temporomandibular Joint Osteoarthritis

Affiliations
Review

Multidisciplinary Rehabilitation after Hyaluronic Acid Injections for Elderly with Knee, Hip, Shoulder, and Temporomandibular Joint Osteoarthritis

Lorenzo Lippi et al. Medicina (Kaunas). .

Abstract

Osteoarthritis (OA) is a prevalent degenerative joint condition characterized by cartilage deterioration, joint inflammation, and functional limitations, particularly impacting the elderly population. Rehabilitation and hyaluronic acid (HA) injections are common therapeutic approaches routinely used in clinical practice, but their synergistic potential is far from being fully characterized. Thus, the aim of this narrative review was to elucidate the multilevel benefits and synergies of integrating these two approaches in multidisciplinary OA rehabilitation. This narrative review follows the scale for the assessment of narrative review articles (SANRA) criteria and involves a comprehensive literature search from July to August 2023. Two independent reviewers screened studies, including those involving human subjects with OA, rehabilitation strategies, and outcomes following HA injection, published in English. Results: HA injections might improve joint biomechanics, reducing friction, absorbing shocks, and potentially regulating inflammation. Rehabilitation plays a pivotal role in strengthening muscles, increasing the range of motion, and enhancing overall function. Optimizing rehabilitation following HA injection might provide additional benefits in joint health. OA management requires a multidisciplinary approach integrating HA injections, rehabilitation, and personalized care. Challenges in patient adherence and healthcare resources currently exist, but emerging technologies offer opportunities to enhance patient engagement and monitoring optimizing sustainability and outcomes of patients with knee, hip, shoulder, and temporomandibular joint OA.

Keywords: hyaluronic acid; joint pain; musculoskeletal rehabilitation; osteoarthritis; pain; prehabilitation; rehabilitation; viscosupplementation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Multicomponent tailored rehabilitation protocols in patients with Osteoarthritis.

Similar articles

Cited by

References

    1. Ackerman I.N., Buchbinder R., March L. Global Burden of Disease Study 2019: An opportunity to understand the growing prevalence and impact of hip, knee, hand and other osteoarthritis in Australia. Intern. Med. J. 2023;53:1875–1882. doi: 10.1111/imj.15933. - DOI - PMC - PubMed
    1. Allen K.D., Thoma L.M., Golightly Y.M. Epidemiology of osteoarthritis. Osteoarthr. Cartil. 2022;30:184–195. doi: 10.1016/j.joca.2021.04.020. - DOI - PMC - PubMed
    1. Hügle T., Geurts J., Nüesch C., Müller-Gerbl M., Valderrabano V. Aging and osteoarthritis: An inevitable encounter? J. Aging Res. 2012;2012:950192. doi: 10.1155/2012/950192. - DOI - PMC - PubMed
    1. Rejeski W.J., Ettinger W.H., Jr., Schumaker S., James P., Burns R., Elam J.T. Assessing performance-related disability in patients with knee osteoarthritis. Osteoarthr. Cartil. 1995;3:157–167. doi: 10.1016/S1063-4584(05)80050-0. - DOI - PubMed
    1. McDonough C.M., Jette A.M. The contribution of osteoarthritis to functional limitations and disability. Clin. Geriatr. Med. 2010;26:387–399. doi: 10.1016/j.cger.2010.04.001. - DOI - PMC - PubMed

Substances